{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:09:57Z","timestamp":1761293397574},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.lfs.2016.03.049","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T09:23:16Z","timestamp":1459934596000},"page":"55-65","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a\/NCX1 pathway"],"prefix":"10.1016","volume":"153","author":[{"given":"Md. Sayeed","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna Kolappa","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Quamrul","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Dhyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Vasim","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.03.049_bb0005","unstructured":"World health organization, 2015. Diabetes. Fact sheet update. Retrieved from http:\/\/www.who.int\/mediacentre\/factsheets\/fs312\/en\/; accessed on 01\/10\/2015."},{"key":"10.1016\/j.lfs.2016.03.049_bb0010","unstructured":"International Diabetic Federation, 2014. IDF diabetes atlas, sixth edition. poster update. Retrieved from http:\/\/www.idf.org\/diabetesatlas\/update-2014."},{"key":"10.1016\/j.lfs.2016.03.049_bb0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.lfs.2016.03.049_bb0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jmri.22879","article-title":"Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve","volume":"35","author":"Korosoglou","year":"2012","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/j.lfs.2016.03.049_bb0025","doi-asserted-by":"crossref","first-page":"C139","DOI":"10.1152\/ajpcell.00020.2010","article-title":"Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis","volume":"299","author":"Rajamani","year":"2010","journal-title":"Am J Physiol Cell Physiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0030","first-page":"103","article-title":"Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients","volume":"59","author":"Tejeda","year":"2007","journal-title":"Rev. Investig. Clin."},{"issue":"5","key":"10.1016\/j.lfs.2016.03.049_bb0035","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jcp.22457","article-title":"Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system","volume":"226","author":"Guleria","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2007.10.021","article-title":"Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options","volume":"51","author":"Witteles","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.lfs.2016.03.049_bb0045","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.2337\/diabetes.53.12.3201","article-title":"Decreased sarcoplasmic reticulum activity and contractility in diabetic db\/db mouse heart","volume":"53","author":"Belke","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2016.03.049_bb0050","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.freeradbiomed.2005.12.009","article-title":"Metallothionein alleviates cardiac dysfunction in streptozotocin induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme","volume":"40","author":"Wold","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2016.03.049_bb0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/ptr.3015","article-title":"Pycnogenol improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats","volume":"24","author":"Klimas","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.lfs.2016.03.049_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death and Disease"},{"key":"10.1016\/j.lfs.2016.03.049_bb0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005344-199505000-00016","article-title":"Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation","volume":"25","author":"Haikala","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(97)01362-9","article-title":"The effects of levosimendan on [Ca2+]I in Guinea-pig isolated ventricular myocytes","volume":"339","author":"Lancaster","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0075","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/S1734-1140(13)71488-9","article-title":"Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo","volume":"65","author":"Godeny","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2016.03.049_bb0080","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/sj.bjp.0706781","article-title":"The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles","volume":"148","author":"Erdei","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01108-4","article-title":"Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes","volume":"333","author":"Yokoshiki","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1211\/0022357001773715","article-title":"Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein","volume":"52","author":"Pataricza","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0095","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0735-1097(00)00961-X","article-title":"Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure","volume":"36","author":"Nieminen","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-200104000-00003","article-title":"Levosimendan increases diastolic coronary flow in isolated Guinea-pig heart by opening ATP-sensitive potassium channels","volume":"37","author":"Kaheinen","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2016.03.049_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"REVIVE heart failure study group. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.lfs.2016.03.049_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart Outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2016.03.049_bb0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejps.2009.09.004","article-title":"Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats","volume":"38","author":"Sharma","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2016.03.049_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1074248411416816","article-title":"Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats","volume":"17","author":"Parveen","year":"2012","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2016.03.049_bb0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12012-011-9122-2","article-title":"Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress","volume":"11","author":"Bhatia","year":"2011","journal-title":"Cardiovasc. Toxicol."},{"issue":"650","key":"10.1016\/j.lfs.2016.03.049_bb0130","first-page":"e1","article-title":"Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart","volume":"212","author":"Wang","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.lfs.2016.03.049_bb0135","first-page":"2200","article-title":"Development of monoclonal antibodied for an assay of cardiac troponin-I and preliminarily results in suspected cases of myocardial infarction","volume":"38","author":"Boder","year":"1992","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2016.03.049_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biomag.2013.10.008","article-title":"Cardioprotective effects of Ficus religiosa in neonatal streptozotocin-induced diabetic cardiomyopathy in rats","volume":"4","author":"Sharma","year":"2014","journal-title":"Biomedicine & Aging Pathology"},{"year":"1993","series-title":"Immunohistochemistry II","key":"10.1016\/j.lfs.2016.03.049_bb0145"},{"key":"10.1016\/j.lfs.2016.03.049_bb0150","first-page":"186","article-title":"Doxorubicin cardiomyopathy in the rat: comparision of electrocardiogram, transmembrane potential and structural effects","volume":"6","author":"Jensen","year":"1984","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.lfs.2016.03.049_bb0160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis Models Mech."},{"key":"10.1016\/j.lfs.2016.03.049_bb0165","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/HJH.0b013e32832f0ce4","article-title":"Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats","volume":"27","author":"Louhelainen","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2016.03.049_bb0170","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejheart.2005.02.002","article-title":"Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine","volume":"7","author":"Avgeropoulou","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2016.03.049_bb0175","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.atherosclerosis.2007.07.011","article-title":"Effects of levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure","volume":"195","author":"Parissis","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2016.03.049_bb0180","first-page":"1","article-title":"Levosimendan suppresses oxidative injury, apoptotic and oxidative stress","volume":"19","author":"Akhtar","year":"2015","journal-title":"Clin. Exp. Hypertens."},{"issue":"9","key":"10.1016\/j.lfs.2016.03.049_bb0185","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1006\/jmcc.1997.0474","article-title":"Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats","volume":"29","author":"Smith","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0925-4439(00)00078-8","article-title":"Influence of diabetes on cardiac nitric oxide synthase expression and activity","volume":"1535","author":"Stockklauser-Farber","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.lfs.2016.03.049_bb0195","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.anes.0000278909.40408.24","article-title":"Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide","volume":"107","author":"Amour","year":"2007","journal-title":"Anesthesiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0200","doi-asserted-by":"crossref","first-page":"H305","DOI":"10.1152\/ajpheart.2000.278.1.H305","article-title":"Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function","volume":"278","author":"Fryer","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0205","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/hh1201.092094","article-title":"Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells","volume":"88","author":"Akao","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2016.03.049_bb0210","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/01.RES.0000247029.31997.a4","article-title":"Signaling mechanisms in ischemic preconditioning: interaction of PKC epsilon and MitoK(ATP) in the inner membrane of mitochondria","volume":"99","author":"Ardehali","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2016.03.049_bb0215","doi-asserted-by":"crossref","first-page":"26G","DOI":"10.1016\/j.amjcard.2005.07.018","article-title":"Cardioprotection: a new paradigm in the management of acute heart failure syndromes","volume":"96","author":"Maytin","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0220","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/hrt.72.6.561","article-title":"Increased circulating cytokines in patients with myocarditis and cardiomyopathy","volume":"72","author":"Matsumori","year":"1994","journal-title":"Br. Heart J."},{"key":"10.1016\/j.lfs.2016.03.049_bb0225","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0230","doi-asserted-by":"crossref","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","article-title":"Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1)","volume":"283","author":"Rosenkranz","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2016.03.049_bb0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amjcard.2006.01.068","article-title":"Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure","volume":"98","author":"Adamopoulos","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0240","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1038\/srep09704","article-title":"Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure","volume":"5","author":"Adam","year":"2015","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.lfs.2016.03.049_bb0245","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","article-title":"Cardiac troponin and outcome in acute heart failure","volume":"358","author":"Peacock","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lfs.2016.03.049_bb0250","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1475-2840-10-97","article-title":"Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis","volume":"10","author":"Kain","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.lfs.2016.03.049_bb0255","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/j.jvca.2008.11.013","article-title":"Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies","volume":"23","author":"Zangrillo","year":"2009","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.lfs.2016.03.049_bb0260","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.lfs.2016.03.049_bb0265","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signaling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1475-2840-13-75","article-title":"Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy","volume":"13","author":"Zhao","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2016.03.049_bb0275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bjp.0707157","article-title":"Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl\/Rapp rats","volume":"150","author":"Louhelainen","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2016.03.049_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.03.049_bb0285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S0265021507002736","article-title":"Effects of levosimendan on myocardial ischaemiareperfusion injury","volume":"25","author":"Yapici","year":"2008","journal-title":"Eur. J. Anaesthesiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516301989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516301989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T06:54:27Z","timestamp":1600412067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516301989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":57,"alternative-id":["S0024320516301989"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.03.049","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a\/NCX1 pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}